-
(单词翻译:双击或拖选)
Broadcast: Jan 11 2003
U.S. and African officials meet next week (13-17 January) in 1)Mauritius for a conference on expanding U.S.-African trade. AIDS activists2 say the meeting will be meaningless without increased U.S. financial support to fight a disease devastating3 African economies.
The Mauritius gathering4 will discuss implementation5 of a U.S. law called the Africa Growth and Opportunity Act, passed during the Clinton presidency6 in 2000 to open U.S. markets to certain African goods.
The law is credited with helping7 2)boost sub-Saharan African exports to the United States by more than 10 percent last year.
But AIDS activists like Asia Russell of the U.S. advocacy group Health GAP say the Bush administration is hurting African economies at the same time by not doing more to combat HIV. "The greatest barrier to the economic livelihood8 of Africa is the continent's AIDS pandemic, and any provision of so-called free trade won't help the dead not the 20 million dead from AIDS already on the continent, nor the 30 million 3)infected with no access to affordable9 medicines that could extend their lives," she says.
The World Health Organization estimates that of these millions of HIV patients, only 300,000 get the drugs that halt the virus'replication. AIDS activists say the United States has undermined efforts to make cheaper HIV medicines available in poor countries in an effort to protect patent rights of large pharmaceutical10 companies.
Washington helped formulate11 a 2001 World Trade Organization compromise in Doha, Qatar that permits developing countries to produce low-cost copies of patented drugs when public health emergencies warrant.
But subsequent talks have failed over the question of how poor countries without drug industries can import generic12 drugs from those than can make them. The United States fears the original agreement will be abused by nations that want to export copies of drugs for non-emergency conditions.
However, Asia Russell of Health GAP accuses Bush administration trade negotiators of impeding13 the talks by insisting on too strict an interpretation14 of the 2001 Doha agreement. "It was White House 4)intransigence15 and pharmaceutical industry greed that killed all hope of reaching a solution within the timeline agreed to by WTO members just a year before," she says. "The White House is running roughshod over its historic commitment set out during the Doha ministerial meeting of the World Trade Organization."
A December statement from U.S. Trade Representative Robert Zoellick says Washington has worked intensively to find a solution that will provide life-saving drugs to those truly in need. While an agreement is sought, he pledges not to challenge any WTO member that breaks the organization's rules on drug export, and asks other members to join this moratorium16.
AIDS activists also criticize the Bush administration for not supplying more money to the Global Fund, formed last year to collect and disperse17 money to countries with 5)epidemic18 AIDS, 6)tuberculosis19, and 7)malaria20. The United States has pledged $500 million to the fund, but many international economists21 and public health and developmental experts say the fair U.S. share is five times more, or $2.5 billion.
In comparison to this need, one leading South African AIDS activist1 dismisses the benefits of the U.S. law promoting trade with Africa as puny22. Zackie Achmat of the Treatment Action Campaign, insists that, in addition to spending more on AIDS, the United States should stop 8)subsidizing farmers, which he says puts African labor23 at a disadvantage. "Where I live, in the last 18 months, more than 100,000 textile and clothing jobs have been lost, particularly because of trade restrictions24. We would like to see fairer trade and most importantly the Bush administration leading the battle on HIV-AIDS," he says.
Asia Russell of Health GAP says she is heartened that the new majority Republican Party leader in the U.S. Senate is Bill Frist, a physician whom she says has shown an interest in making African AIDS a key U.S. policy issue.
David McAlary, VOA news, Washington.
1) Mauritius n.毛里求斯(非洲岛国)
2) boost [bu:st]v.推进
3) infect[in5fekt]vt.[医] 传染, 感染
4) intransigence [in5trAnsidVEns]n.不妥协态度, 不让步,不调和
5) epidemic [7epi5demik]adj.流行的, 传染的, 流行性
6) tuberculosis [tju7bE:kju5lEusis]n.肺结核
7) malaria [mE5lZEriE]n.疟疾, 瘴气
8) subsidize[5sQbsidaiz]v.资助, 津贴
1 activist | |
n.活动分子,积极分子 | |
参考例句: |
|
|
2 activists | |
n.(政治活动的)积极分子,活动家( activist的名词复数 ) | |
参考例句: |
|
|
3 devastating | |
adj.毁灭性的,令人震惊的,强有力的 | |
参考例句: |
|
|
4 gathering | |
n.集会,聚会,聚集 | |
参考例句: |
|
|
5 implementation | |
n.实施,贯彻 | |
参考例句: |
|
|
6 presidency | |
n.总统(校长,总经理)的职位(任期) | |
参考例句: |
|
|
7 helping | |
n.食物的一份&adj.帮助人的,辅助的 | |
参考例句: |
|
|
8 livelihood | |
n.生计,谋生之道 | |
参考例句: |
|
|
9 affordable | |
adj.支付得起的,不太昂贵的 | |
参考例句: |
|
|
10 pharmaceutical | |
adj.药学的,药物的;药用的,药剂师的 | |
参考例句: |
|
|
11 formulate | |
v.用公式表示;规划;设计;系统地阐述 | |
参考例句: |
|
|
12 generic | |
adj.一般的,普通的,共有的 | |
参考例句: |
|
|
13 impeding | |
a.(尤指坏事)即将发生的,临近的 | |
参考例句: |
|
|
14 interpretation | |
n.解释,说明,描述;艺术处理 | |
参考例句: |
|
|
15 intransigence | |
n.妥协的态度;强硬 | |
参考例句: |
|
|
16 moratorium | |
n.(行动、活动的)暂停(期),延期偿付 | |
参考例句: |
|
|
17 disperse | |
vi.使分散;使消失;vt.分散;驱散 | |
参考例句: |
|
|
18 epidemic | |
n.流行病;盛行;adj.流行性的,流传极广的 | |
参考例句: |
|
|
19 tuberculosis | |
n.结核病,肺结核 | |
参考例句: |
|
|
20 malaria | |
n.疟疾 | |
参考例句: |
|
|
21 economists | |
n.经济学家,经济专家( economist的名词复数 ) | |
参考例句: |
|
|
22 puny | |
adj.微不足道的,弱小的 | |
参考例句: |
|
|
23 labor | |
n.劳动,努力,工作,劳工;分娩;vi.劳动,努力,苦干;vt.详细分析;麻烦 | |
参考例句: |
|
|
24 restrictions | |
约束( restriction的名词复数 ); 管制; 制约因素; 带限制性的条件(或规则) | |
参考例句: |
|
|